AOH

Gulf Sriracha Power Plant Recognized as Power Plant of the Year at Enlit Asia 2023 Power and Energy Awards

Retrieved on: 
Tuesday, December 26, 2023
Gulf Group, Power, JAC, Partnership, EGAT, AOH, EPC, Mitsui, GTCC, Plant, Exhibition, Carbon, Safety, Amphoe Nong Saeng, Renewable energy

SINGAPORE, Dec 26, 2023 - (JCN Newswire) - The Gulf Sriracha Power Plant, a joint venture between Thai Independent Power Provider Gulf Energy Development Company Limited and Japanese trading company Mitsui & Co., Ltd, and developed by Mitsubishi Power, has won the distinguished "Power Plant of the Year" title at the Power and Energy Awards.

Key Points: 
  • SINGAPORE, Dec 26, 2023 - (JCN Newswire) - The Gulf Sriracha Power Plant, a joint venture between Thai Independent Power Provider Gulf Energy Development Company Limited and Japanese trading company Mitsui & Co., Ltd, and developed by Mitsubishi Power, has won the distinguished "Power Plant of the Year" title at the Power and Energy Awards.
  • Situated in Thailand's Chonburi province, the 2,650 megawatts (MW) gas turbine combined cycle (GTCC) power plant broke ground in 2018.
  • Ltd, said: "This recognition at the Power and Energy Awards further demonstrates the exceptional achievements of the Gulf Sriracha Power Plant.
  • These plants, operational by 2014 and 2015, demonstrated excellence, contributing significantly to the partnership on the Gulf Sriracha Power Plant.

Mitsubishi Power Begins Commercial Operation of Sixth M701JAC Gas Turbine for Thailand GTCC Power Plants; Project Achieves 50,000 AOH

Retrieved on: 
Thursday, October 12, 2023
Senior, COVID-19, Unit, Assistant director, Plant, AOH, Mitsubishi Power Systems Europe, Mitsui & Co., Project, Electricity Generating Authority of Thailand, MHI, Business administration, Economic development, Trust, Electricity, Mitsui, Maintenance, GTCC, JAC, EGAT, Mitsubishi Heavy Industries, Construction, Oil, Rare-earth element, Management, Renewable energy

TOKYO, Oct 12, 2023 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has completed installation of the second of four M701JAC units at a natural gas-fired power plant project in Rayong Province, Thailand.

Key Points: 
  • TOKYO, Oct 12, 2023 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has completed installation of the second of four M701JAC units at a natural gas-fired power plant project in Rayong Province, Thailand.
  • Operation commenced on 1 October 2023, and follows the start of operations for the first unit at the end of March.
  • The previous five units for the project have exceeded 50,000 actual operating hours (AOH), demonstrating the reliability of the state-of-the-art JAC gas turbines.
  • The overall project encompasses two GTCC power generation plants, each with four power trains comprising a gas turbine, steam turbine, heat recovery steam generator, and generator.

INESSS Recommends Public Reimbursement for BioCryst’s ORLADEYO® (berotralstat) for the Prevention of Attacks for Hereditary Angioedema Patients in Québec

Retrieved on: 
Monday, September 18, 2023
AOH, FRCP, Attack, Hereditary angioedema, BioCryst Pharmaceuticals, Doctor of Philosophy, RESEARCH, HAE, Patient, CADTH, Health Canada, PARK, Caregiver, Disease, Pharmaceutical industry

“While much progress has been made on behalf of the HAE community in Québec, people living with HAE continue to be in need of additional treatment options to help manage their HAE attacks.

Key Points: 
  • “While much progress has been made on behalf of the HAE community in Québec, people living with HAE continue to be in need of additional treatment options to help manage their HAE attacks.
  • Additionally, this recommendation is a step forward as it highlights the need for continued, and simple access for people living with HAE, and their caregivers,” said Charles St-Pierre, president of Hereditary Angioedema Québec (AOH Québec).
  • “As a physician who treats HAE patients, I see first hand how people respond to different HAE treatments, and not every patient’s experience is the same.
  • Health Canada authorized ORLADEYO in June 2022 for the routine prevention of recurrent HAE attacks in patients 12 years and older.

Mitsubishi Power Begins Commercial Operation of Fifth M701JAC Gas Turbine in Thailand GTCC Power Plant Project

Retrieved on: 
Wednesday, April 19, 2023
Gulf Energy Thermal Power Station, Electricity Generating Authority of Thailand, AOH, Electricity, Mitsubishi Heavy Industries, COVID-19, EGAT, Plant, GTCC, Mitsubishi Power Systems Europe, MHI, Mitsui & Co., Engineering, Economic development, JAC, Renewable energy, Mitsui, Chonburi

Mitsubishi Power has delivered five of the gas turbines within the contract delivery period, and the two plants are expected to be in commercial operation by October 2024.

Key Points: 
  • Mitsubishi Power has delivered five of the gas turbines within the contract delivery period, and the two plants are expected to be in commercial operation by October 2024.
  • All four units of the Chonburi power plant commenced commercial operation in October 2022 and have exceeded 25,000 actual operating hours (AOH), demonstrating the reliability of the state-of-the-art JAC gas turbines.
  • The overall project encompasses two GTCC power generation plants, each with four power trains comprising a gas turbine, steam turbine, heat recovery steam generator, and generator.
  • We look forward to continued collaboration with Mitsubishi Power and other partners to ensure the success of this project."

Mitsubishi Power Achieves #1 Global Gas Turbine Market Share in 2022 According to McCoy Power Report

Retrieved on: 
Thursday, March 9, 2023
Natural gas, Mitsubishi Heavy Industries, J series, Carbon, Mitsubishi Power Systems Europe, Energy transition, JAC, Education minister, MHI, F. G. M. Chancellor, AOH, Energy, Hydrogen, Renewable energy, Coal

- Cumulative orders for J-series gas turbines surpassed 100 units, contributing to the company's top market share

Key Points: 
  • - Cumulative orders for J-series gas turbines surpassed 100 units, contributing to the company's top market share
    TOKYO, Mar 9, 2023 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), captured the top market share by megawatts in 2022 with a global gas turbine market share of 33% according to McCoy Power Reports data.
  • (1) The company has also secured 49% market share in the Advanced Class(2) gas turbine market, led by Mitsubishi Power's latest model JAC (J-Series Air-Cooled) gas turbines.
  • Mitsubishi Power's high market share results is attributed to its strong project execution track record, high performance, and product reliability.
  • (1) This is based on the McCoy Power Report in the United States, which provides detailed market research on global power generation projects.

Bionano Announces Two Publications from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing including the First Peer-Reviewed Publication on the Multi-Site Evaluation of OGM Against SOC

Retrieved on: 
Thursday, March 2, 2023
DSM-IV codes, SOC, Doctor of Philosophy, Spectrum, Phenotype, Genomics, Clinical trial, OGM, University, University of Rochester, Polyploidy, Workflow, FMR1, Patient, Aneuploidy, SVS, Medical college, Genetic disorder, FACMG, Standard of care, Publication, SAN, University of Rochester Medical Center, Diagnosis, Chromosomal translocation, CNV, ASD, Intellectual disability, AOH, Dietary supplement, Pharmaceutical industry, Medical device, Mail order, Cryptocurrency, Genetic distance, 7p22.1 microduplication syndrome

describes the multi-site evaluation of optical genome mapping (OGM) for postnatal genetic disorders with 404 samples and shows:

Key Points: 
  • describes the multi-site evaluation of optical genome mapping (OGM) for postnatal genetic disorders with 404 samples and shows:
    Pre-print publication from Broeckel, et al.
  • The clinical trial is designed to compare OGM to SOC, including concordance, reproducibility, technical success rate and the rate of detecting reportable findings in cases.
  • A peer-reviewed publication covered an interim readout of the study, which showed OGM’s high technical performance and reproducibility across sites versus SOC analysis.
  • Key findings were reported as follows:
    The pre-print publication describes OGM performance metrics compared to SOC methods for challenging samples from diagnosed and undiagnosed rare diseases.

Mitsubishi Power Completes Mega 2,650 MW GTCC Power Plant in Thailand

Retrieved on: 
Thursday, October 6, 2022
Adoption, Quality of life, Trust, Time, GTCC, Electricity Generating Authority of Thailand, Achievement, Mitsubishi Heavy Industries, MHI, Mitsubishi Power Systems Europe, Carbon, AOH, Senior, Gulf Energy Thermal Power Station, Electricity, Economic development, Energy transition, Construction, Travel, COVID-19, Solution, Engineering, Power, Renewable energy, Motor vehicle, Mitsui, Chonburi

TOKYO, Oct 6, 2022 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has commenced operation of the fourth and final M701JAC unit at an ultra-large-scale natural gas-fired power plant in Chonburi Province, Thailand, on 1 October 2022.

Key Points: 
  • TOKYO, Oct 6, 2022 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has commenced operation of the fourth and final M701JAC unit at an ultra-large-scale natural gas-fired power plant in Chonburi Province, Thailand, on 1 October 2022.
  • Construction of the second power plant project is currently underway in Rayong Province.
  • The Chonburi power plant is located approximately 130 km southeast of Bangkok, and is operated by the joint venture Gulf SRC Company Limited*.
  • The GTCC power generation equipment in this project consists of four power trains per power plant, each made up of four subsystems: a M701JAC gas turbine, steam turbine, heat recovery steam generator, and generator.

Mitsubishi Power's State-of-the-Art M701JAC Gas Turbine Exceeds 8,000 Actual Operating Hours

Retrieved on: 
Tuesday, September 6, 2022
Hydrogen, MHI, Plant, Takasago, Solution, IPP, Carbon, Juniper J series, Achievement, Intelligence, Temperature, JAC, Mitsubishi Heavy Industries, WWE Performance Center, Energy transition, GTCC, Quality of life, Adoption, Mitsubishi Power Systems Europe, AOH, Mitsui, Economic development, Energy, Industry, Efficiency, Mitsui & Co., Renewable energy, Chonburi Province

TOKYO, Sept 6, 2022 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has achieved an accumulated 8,000 hours of actual operating hours (AOH) for its M701JAC gas turbine.

Key Points: 
  • TOKYO, Sept 6, 2022 - (JCN Newswire) - Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has achieved an accumulated 8,000 hours of actual operating hours (AOH) for its M701JAC gas turbine.
  • The subject gas turbine unit was installed for gas turbine combined cycle (GTCC) power generation system operated as part of a joint venture between Thailand's Gulf Energy Development Public Company Limited, one of the country's largest independent power producers (IPP), and Mitsui & Co., Ltd.
  • This achievement provides even more solid evidence of the reliability of JAC Series gas turbines.
  • Of these, 52 units are currently in commercial operation, with aggregate operating hours exceeding 1.7 million hours for the J Series as a whole.

REDLEGG ANNOUNCES IDENTITY ACCESS MANAGEMENT SERVICES PRACTICE - AOH

Retrieved on: 
Monday, June 13, 2022
Cloud, Zero, Architecture, Forrester Research, Privacy, Intelligence Identities Protection Act, Environment, IAM, Compliance, Customer, AOH, Multimedia, Solution, Technology, Online shopping

ST. CHARLES, Ill., June 13, 2022 /PRNewswire/ -- Technology company AOH is coming out full throttle with Cloud Identity Access Management Services focused on Customer IAM, Workforce IAM, Azure Cloud Security & Identity Protection for public & private sector.

Key Points: 
  • ST. CHARLES, Ill., June 13, 2022 /PRNewswire/ -- Technology company AOH is coming out full throttle with Cloud Identity Access Management Services focused on Customer IAM, Workforce IAM, Azure Cloud Security & Identity Protection for public & private sector.
  • Due to the complexity yet importance of identity, a new practice was established.
  • AOH assist enterprises with developing IAM roadmaps, designing & securing IAM architecture solutions.
  • "Next possible frontier for IAM solution will be the merge of current IAM system withuser and entity behavior analytics (UEBA) capability to achieve real-time identity remediation."

Bionano Genomics Announces Major Updates to Its Solve™ and Access™ Data Solutions Adding Significant New Variant Detection, Analysis and Reporting Capabilities for Optical Genome Mapping on the Saphyr® System

Retrieved on: 
Wednesday, November 3, 2021
Autism, Biology, Research, Technology, Genomics, SAN, Cancer, Genome, ISCN, International system, Fragile, IBD, Polyploidy, Lineagen, UPD, Lists of publishing companies, Family, Security (finance), U.S. Securities and Exchange Commission, OGM, Patient, Adoption, Private Securities Litigation Reform Act, SVS, Solve, AOH, Medicine, Access, Software, Hospital Insurance and Diagnostic Services Act, Annual report, Forward-looking statement, Company, CEO, COVID-19, Laboratory, Lists of diseases, SNP, Solution, Acquisition, Classification, VAF, GLOBE, Doctor of Philosophy, Medical imaging, Risk management

The updates will also enable users to visualize chromosomal AOH across the genome similarly to single nucleotide polymorphism (SNP) microarrays.

Key Points: 
  • The updates will also enable users to visualize chromosomal AOH across the genome similarly to single nucleotide polymorphism (SNP) microarrays.
  • Also as part of this release, the family of EnFocustargeted analysis panels now includes one for Fragile X, a repeast expansion disorder.
  • Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine.
  • The Companys mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software.